Copyright 2012 Medical News TodayLatest Health News and Medical News posted throughout the day, every day.http://www.medicalnewstoday.com/sections/pharma_industry/admin@medicalnewstoday.com (MNT Admin)editors@medicalnewstoday.com (MNT Editors)en-us Fri, 10 Feb 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/241297.phphttp://www.medicalnewstoday.com/releases/241297.phpAs a preview to the Biosimilar Drug Development World Europe 2012 conference we asked one of the key speakers Prof Heinz Haenel, Diabetes Division R+D Projects at Sanofi Aventis his thoughts on the current state of the industry. Prof Haenel will be at the conference presenting "Biosimilars - the devil is in the detail"...Pharma Industry / Biotech Industry Tue, 07 Feb 2012 01:00:00 PSThttp://www.medicalnewstoday.com/releases/241222.phphttp://www.medicalnewstoday.com/releases/241222.phpNorth Carolina State University researchers have created specially engineered mammalian cells to provide a new "chemical handle" which will enable researchers to label proteins of interest more efficiently, without disrupting the normal function of the proteins themselves or the cells in which they are found...Pharma Industry / Biotech Industry Fri, 03 Feb 2012 10:00:00 PSThttp://www.medicalnewstoday.com/articles/241159.phphttp://www.medicalnewstoday.com/articles/241159.phpPreparations are underway at the European Medicines Agency together with European Member States and the European Commission, for the introduction of the new pharmacovigilance legislation in July this year. The new legislation will represent the biggest change to the legal framework since The Agency was founded in 1995...Pharma Industry / Biotech Industry Thu, 02 Feb 2012 01:00:00 PSThttp://www.medicalnewstoday.com/releases/241040.phphttp://www.medicalnewstoday.com/releases/241040.php Major blockbuster drugs are facing the end of their era and big pharma companies are bracing for the effect in hopes that they will find a solution for their dwindling pipelines. Thus new opportunities and challenges are rising in the practice of open innovation and Fleming Europe will be there to explore them...Conferences Wed, 01 Feb 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240868.phphttp://www.medicalnewstoday.com/releases/240868.php NextLevel Pharma's "Advancing clinical research in Turkey, the Middle East and North Africa" conference will bring together the local regulators and ethics committees, alongside experienced investigators and study personnel, as well as clinical trial experts from pharma and CROs...Conferences Tue, 31 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240866.phphttp://www.medicalnewstoday.com/releases/240866.phpAsian markets are increasingly the focus of pharmaceutical companies who are looking for new market opportunities beyond the traditional "rich-world" countries who are facing economic stagnation...Conferences Mon, 30 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240867.phphttp://www.medicalnewstoday.com/releases/240867.phpThis unique and timely event will highlight how different frameworks and initiatives have succeeded in developing an efficient, environmentally friendly manufacturing process in the pharmaceutical industry...Conferences Mon, 23 Jan 2012 01:00:00 PSThttp://www.medicalnewstoday.com/releases/240624.phphttp://www.medicalnewstoday.com/releases/240624.phpShortages of key drugs used to fight infections represent a public health emergency and can put patients at risk, according to a review published in Clinical Infectious Diseases and available online*...Infectious Diseases / Bacteria / Viruses Fri, 20 Jan 2012 05:00:00 PSThttp://www.medicalnewstoday.com/releases/240570.phphttp://www.medicalnewstoday.com/releases/240570.phpOrphan drug development has become more feasible than in previous years but we've barely scratched the surface: only 367 approved orphan drugs out of 6,800 rare diseases. We need to keep the momentum going. Come April 10-13, over 300 key decision makers from orphan drug manufacturers, patient groups, payers and regulators will gather in DC at the 2nd annual World Orphan Drug Congress USA...Conferences Fri, 20 Jan 2012 01:00:00 PSThttp://www.medicalnewstoday.com/releases/240531.phphttp://www.medicalnewstoday.com/releases/240531.phpComplianceOnline, the leading governance, risk and compliance advisory network with over 500 experts in various regulatory subjects, today announced a seminar on The A to Z's of Microbial Control, Monitoring and Validation of Pharmaceutical Water Systems. The two day long, in-person seminar, led by well known water systems expert T.C...Conferences Thu, 19 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240431.phphttp://www.medicalnewstoday.com/releases/240431.php The most effective anti-malaria drug can now be produced inexpensively and in large quantities. This means that it will be possible to provide medication for the 225 million malaria patients in developing countries at an affordable price...Tropical Diseases Wed, 18 Jan 2012 06:00:00 PSThttp://www.medicalnewstoday.com/releases/240447.phphttp://www.medicalnewstoday.com/releases/240447.phpDriving development through strategic outsourcingRegister NOW for the Clinical Outsourcing World conference to hear from the industry's BEST Outsourcing professionals including representatives from: GSK, Pfizer, AstraZeneca, Eli Lilly, Novartis, Almirall, Merck Research Laboratories and many more! Pharma & Biotech delegates- register NOW for only £250+vat! Please note this ...Conferences Tue, 17 Jan 2012 15:00:00 PSThttp://www.medicalnewstoday.com/articles/240406.phphttp://www.medicalnewstoday.com/articles/240406.phpFraudulent and substandard antimalarial drugs could be wrecking the chances of winning the war against malaria in Africa, researchers from the Wellcome Trust-Mahosot Hospital-Oxford University Tropical Medicine Research Collaboration reported in the Malaria Journal...Tropical Diseases Tue, 17 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240342.phphttp://www.medicalnewstoday.com/releases/240342.phpMassachusetts General Hospital (MGH) investigators have developed a novel strategy to protect the liver from drug-induced injury and improve associated drug safety...Liver Disease / Hepatitis Mon, 16 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240315.phphttp://www.medicalnewstoday.com/releases/240315.php The number of pharmaceutical products entering the market has declined in the last decade. With the economic downturn and increasing threat from generic companies, pharmaceutical companies have never been under greater pressure to develop new innovative drugs...Conferences Sun, 15 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240313.phphttp://www.medicalnewstoday.com/releases/240313.php SMi is proud to present their 6th annual Pharmaceutical Parallel Trade Conference, taking place on 6th & 7th February 2012 at the Copthorne Tara Hotel in London. This year's event will bring together expert speakers from different sectors within the industry, each with differing opinions and perspectives to offer...Conferences Sat, 14 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240292.phphttp://www.medicalnewstoday.com/releases/240292.phpA team of researchers at the California Institute of Technology (Caltech) has devised a new method for making complex molecules...Pharma Industry / Biotech Industry Thu, 12 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/240176.phphttp://www.medicalnewstoday.com/releases/240176.phpScientists at the University of Leicester have opened up a whole new approach to the therapeutic intervention for a family of anti-cancer drug targets, thanks to a completely new and unexpected finding...Cancer / Oncology Mon, 09 Jan 2012 12:00:00 PSThttp://www.medicalnewstoday.com/articles/240080.phphttp://www.medicalnewstoday.com/articles/240080.php Novartis Consumer Health announced earlier today a recall on certain OTC medicines that were badly packaged and might have broken or chipped pills, as well as incorrect product mixed into bottles of pills. Rather worrying for consumers with risks of possible wrong or overdoses of their medicine...Pharma Industry / Biotech Industry Mon, 09 Jan 2012 09:00:00 PSThttp://www.medicalnewstoday.com/articles/240079.phphttp://www.medicalnewstoday.com/articles/240079.php Complaints of chipped and broken pills as well as inconsistent packaging have promoted Novartis Consumer Health Inc. (NCH) to recall certain lots of its products. Whilst there have been no reports of adverse effects to patients so far, Novartis has also warned of possible mixing of product. They have asked consumers to dispose of the product or return unused bottles...Pharma Industry / Biotech Industry Sun, 08 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/239996.phphttp://www.medicalnewstoday.com/releases/239996.php Drugs already approved for clinical use across a variety of therapeutic categories can be screened to identify effective agents for thyroid cancer according to a recent study accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). These findings could rapidly be implemented into a clinical trial to test how effective the treatment would be...Cancer / Oncology Fri, 06 Jan 2012 10:00:00 PSThttp://www.medicalnewstoday.com/releases/240034.phphttp://www.medicalnewstoday.com/releases/240034.phpWith the recent changes to regulations about interactions with external stakeholders, it can be hard to keep up to date. Eyeforpharma spoke to Julian Jenkins, Head of Global Medical Affairs at Ferring Pharmaceuticals about how to work compliantly under the changing regulatory environment...Conferences Thu, 05 Jan 2012 00:00:00 PSThttp://www.medicalnewstoday.com/releases/239899.phphttp://www.medicalnewstoday.com/releases/239899.phpThe delivery of pharmaceuticals into the human body or the storage of voluminous quantities of gas molecules could now be better controlled, thanks to a study by University of Pittsburgh researchers. In a paper published online in Nature Communications, a team of chemists and colleagues from Pitt's Kenneth P...Pharma Industry / Biotech Industry Tue, 03 Jan 2012 01:00:00 PSThttp://www.medicalnewstoday.com/releases/239808.phphttp://www.medicalnewstoday.com/releases/239808.phpBioDelivery Sciences International, Inc. (Nasdaq: BDSI) responded to the approval and announcement by the U.S. Food and Drug Administration (FDA) that a Risk Evaluation Mitigation Strategy (REMS) covering all transmucosal fentanyl products has been approved...Pain / Anesthetics Tue, 03 Jan 2012 01:00:00 PSThttp://www.medicalnewstoday.com/releases/239809.phphttp://www.medicalnewstoday.com/releases/239809.phpProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), and an international specialty pharmaceutical company, announces that the U.S. Food and Drug Administration (FDA) has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS (Risk Evaluation and Mitigation Strategy) Access program...Pain / Anesthetics